Dopamine Agonists [Pharmacological Action]
Tree Number(s): D018491
MeSH Unique ID: D018491
- dironyl (Supplementary Concept)
- N-n-propylnorapomorphine (Supplementary Concept)
- carbidopa, levodopa drug combination (Supplementary Concept)
- stepholidine (Supplementary Concept)
- ADTN (Supplementary Concept)
- (3,4-dihydroxyphenylamino)-2-imidazoline (Supplementary Concept)
- N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride (Supplementary Concept)
- ibopamine (Supplementary Concept)
- talipexole (Supplementary Concept)
- preclamol (Supplementary Concept)
- 7-hydroxy-2-N,N-dipropylaminotetralin (Supplementary Concept)
- mesulergine (Supplementary Concept)
- 3-N-methylspiperone (Supplementary Concept)
- 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine (Supplementary Concept)
- 2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin (Supplementary Concept)
- naxagolide (Supplementary Concept)
- dopexamine (Supplementary Concept)
- ropinirole (Supplementary Concept)
- quinagolide (Supplementary Concept)
- rotigotine (Supplementary Concept)
- quinelorane (Supplementary Concept)
- docarpamine (Supplementary Concept)
- CY 208-243 (Supplementary Concept)
- 1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine (Supplementary Concept)
- N-(2-chloro-6-methylergoline-8-yl)-2,2-dimethylpropanamide (Supplementary Concept)
- roxindole (Supplementary Concept)
- dihydrexidine (Supplementary Concept)
- 3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol (Supplementary Concept)
- NCQ 298 (Supplementary Concept)
- A 68930 (Supplementary Concept)
- SK and F 81297 (Supplementary Concept)
- SK and F 77434 (Supplementary Concept)
- fananserin (Supplementary Concept)
- SK and F 82958 (Supplementary Concept)
- alnespirone (Supplementary Concept)
- A 77636 (Supplementary Concept)
- 3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine (Supplementary Concept)
- ergocryptine (Supplementary Concept)
- N-((4-(2-cyanophenyl)piperazinyl)methyl)benzamide (Supplementary Concept)
- PD 158771 (Supplementary Concept)
- BP 897 (Supplementary Concept)
- 2-(4-(2-cyanophenyl)-1-piperazinyl)-N-(3-methylphenyl) acetamide (Supplementary Concept)
- brexpiprazole (Supplementary Concept)
- PF-06669571 (Supplementary Concept)
- Apomorphine (MeSH Term)
- Bromocriptine (MeSH Term)
- Dihydroergotamine (MeSH Term)
- Dihydroergotoxine (MeSH Term)
- Lisuride (MeSH Term)
- Metergoline (MeSH Term)
- Pergolide (MeSH Term)
- Piribedil (MeSH Term)
- 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine (MeSH Term)
- Fenoldopam (MeSH Term)
- Quinpirole (MeSH Term)
- Dihydroergocornine (MeSH Term)
- Dihydroergocryptine (MeSH Term)
- Aripiprazole (MeSH Term)
- Cabergoline (MeSH Term)
- Pramipexole (MeSH Term)